All Stories

  1. The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability
  2. Prolactin regulates liver growth during postnatal development in mice
  3. Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
  4. Impaired prolactin actions mediate altered offspring metabolism induced by maternal high‐fat feeding during lactation
  5. From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis
  6. Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases
  7. Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference
  8. Vasoinhibins May Contribute to Postpartum Depression
  9. Vasoinhibin Suppresses the Neurotrophic Effects of VEGF and NGF in Newborn Rat Primary Sensory Neurons
  10. Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase
  11. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis
  12. Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy
  13. Chapter 14. From Reproductive Neuroendocrinology and Lactation to Vasoinhibins and Angiogenesis
  14. Vasoinhibin Serum Levels Are Required to Demonstrate Their Role in Peripartum Cardiomyopathy Etiopathology
  15. Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome
  16. Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity
  17. Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males
  18. The vasoinhibin solution structure appears unfolded, dynamic, and features aggregation
  19. Serum proteases do not cleave prolactin to vasoinhibins at physiological pH
  20. The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview
  21. Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1
  22. Principles of the prolactin/vasoinhibin axis
  23. Prolactin anterior pituitary expression and circulating levels are reduced in obese and diabetic rats: role of TGF-β and TNF-α
  24. On the Path toward Classifying Hormones of the Vasoinhibin-Family
  25. High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function
  26. Regulation of Blood Vessels by Prolactin and Vasoinhibins
  27. Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress
  28. Arthritis and prolactin: A phylogenetic viewpoint
  29. Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors
  30. Vasoinhibins are natural inhibitors of angiogenesis in the vitreous and are impaired in patients with diabetic retinopathy
  31. Prolactin administration during early postnatal life decreases hippocampal and olfactory bulb neurogenesis and results in depressive-like behavior in adulthood
  32. Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis
  33. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis
  34. Requirement of phosphorylatable endothelial nitric oxide synthase at Ser-1177 for vasoinhibin-mediated inhibition of endothelial cell migration and proliferation in vitro
  35. Prolactin and blood vessels: A comparative endocrinology perspective
  36. Vasoinhibin Gene Transfer by Adenoassociated Virus Type 2 Protects against VEGF- and Diabetes-Induced Retinal Vasopermeability
  37. Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy
  38. Peripheral regulation of prolactin by oxytocin: focus on “Systemic oxytocin induces a prolactin secretory rhythm via the pelvic nerve in ovariectomized rats”
  39. Vasoinhibins Prevent Bradykinin-Stimulated Endothelial Cell Proliferation by Inactivating eNOS via Reduction of both Intracellular Ca2+ Levels and eNOS Phosphorylation at Ser1179
  40. N-Terminal Prolactin-Derived Fragments, Vasoinhibins, Are Proapoptoptic and Antiproliferative in the Anterior Pituitary
  41. Prolactin Promotes Liver Regeneration after Partial Hepatectomy
  42. Prolactin promotes oxytocin and vasopressin release by activating neuronal nitric oxide synthase in the supraoptic and paraventricular nuclei
  43. High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
  44. Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
  45. Prolactin and Vasoinhibins Exert Opposite Effects on Chondrocyte Survival.
  46. Vasoinhibins and the Pituitary Gland
  47. Prolactin in Ovarian Follicular Fluid Stimulates Endothelial Cell Proliferation
  48. Cathepsin D Is the Primary Protease for the Generation of Adenohypophyseal Vasoinhibins: Cleavage Occurs within the Prolactin Secretory Granules
  49. Peptide Hormone Regulation of Angiogenesis
  50. Effects of prolactin deficiency during the early postnatal period on the development of maternal behavior in female rats: Mother's milk makes the difference
  51. Effects of prolactin and vasoinhibins on nitric oxide synthase activity in coronary endothelial cells and vessels in isolated perfused guinea pig hearts
  52. Vasoinhibins: novel inhibitors of ocular angiogenesis
  53. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A–dependent eNOS inactivation
  54. Expression and cellular localization of prolactin and the prolactin receptor in mammalian retina
  55. Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland
  56. Hormones and postpartum cardiomyopathy
  57. Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia
  58. Prolactin-like hormone in the nematode Trichinella spiralis larvae
  59. In vivo transcriptional targeting into the retinal vasculature using recombinant baculovirus carrying the human flt-1 promoter
  60. 17-Beta-Estradiol Directly Regulates the Expression of Adrenergic Receptors and Kisspeptin/GPR54 System in GT1-7 GnRH Neurons
  61. GABA Inhibition of Cyclic AMP Production in Immortalized GnRH Neurons Is Mediated by Calcineurin-Dependent Dephosphorylation of Adenylyl Cyclase 9
  62. Vasoinhibins: endogenous regulators of angiogenesis and vascular function
  63. Aquaporin-1: a novel promoter of tumor angiogenesis
  64. Vasoinhibins: A Family of N-Terminal Prolactin Fragments that Inhibit Angiogenesis and Vascular Function
  65. Opposite Association of Serum Prolactin and Survival in Patients with Colon and Rectal Carcinomas: Influence of Preoperative Radiotherapy
  66. Prolactins Are Natural Inhibitors of Angiogenesis in the Retina
  67. Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells
  68. 16K-Prolactin Inhibits Activation of Endothelial Nitric Oxide Synthase, Intracellular Calcium Mobilization, and Endothelium-Dependent Vasorelaxation
  69. Cathepsin D Processes Human Prolactin into Multiple 16K-Like N-Terminal Fragments: Study of Their Antiangiogenic Properties and Physiological Relevance
  70. Prolactin in Eyes of Patients with Retinopathy of Prematurity: Implications for Vascular Regression
  71. In vivo release and gene upregulation of brain prolactin in response to physiological stimuli
  72. Hypoxia Inhibits Expression of Prolactin and Secretion of Cathepsin-D by the GH4C1 Pituitary Adenoma Cell Line
  73. Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibroblasts
  74. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells
  75. Prolactin and 16K Prolactin Stimulate Release of Vasopressin by a Direct Effect on Hypothalamo-Neurohypophyseal System
  76. Increased hypothalamic expression of prolactin in lactation: involvement in behavioural and neuroendocrine stress responses
  77. Regulation of Gonadotropin-Releasing Hormone Secretion
  78. GABA Inhibition of Immortalized Gonadotropin-Releasing Hormone Neuronal Excitability Involves GABAA
  79. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus
  80. Proteolytic Cleavage Confers Nitric Oxide Synthase Inducing Activity upon Prolactin
  81. Functional uncoupling between intracellular calcium dynamics and secretion in the αT3‐1 gonadotropic cell line
  82. Functional uncoupling between intracellular calcium dynamics and secretion in the ?T3-1 gonadotropic cell line
  83. Potentiation of Prolactin Secretion following Lactotrope Escape from Dopamine Action
  84. Potentiation of Prolactin Secretion following Lactotrope Escape from Dopamine Action
  85. Prolactins: Novel Regulators of Angiogenesis
  86. Differential effects of basic fibroblast growth factor, epidermal growth factor, transforming growth factor‐α, and insulin‐like growth factor‐I on a hypothalamic gonadotropin‐releasing hormone neuronal cell line
  87. Differential effects of basic fibroblast growth factor, epidermal growth factor, transforming growth factor-?, and insulin-like growth factor-I on a hypothalamic gonadotropin-releasing hormone neuronal cell line
  88. Immunoreactive Prolactin Forms Colocalize with Vasopressin in Neurons of the Hypothalamic Paraventricular and Supraoptic Nuclei
  89. The catecholaminergic stimulation of gonadotropin-releasing hormone release by GT1-1 cells does not involve phosphoinositide hydrolysis
  90. A 14-kilodalton prolactin-like fragment is secreted by the hypothalamo-neurohypophyseal system of the rat.
  91. Immunoreactive prolactins of the neurohypophyseal system display actions characteristic of prolactin and 16K prolactin
  92. Histamine directly stimulates gonadotropin-releasing hormone secretion from GT1-1 cells via H1 receptors coupled to phosphoinositide hydrolysis.
  93. Changes in molecular variants during in vitro transformation and release of prolactin by the pituitary gland of the lactating rat.
  94. The 16K Fragment of Prolactin Specifically Inhibits Basal or Fibroblast Growth Factor Stimulated Growth of Capillary Endothelial Cells
  95. Age-related stimulatory and inhibitory effects of suckling regulate lactation in rabbits
  96. Prolactin and propranolol prevent the suckling-induced inhibition of lactation in rabbits
  97. Regulation of Prolactin Secretion by Dopamine and Thyrotropin-Releasing Hormone in Lactating Rat Adenohypophyses: Influence of Intracellular Age of the Hormone*
  98. Binding Studies with Intact Rat Prolactin and a 16K Fragment of the Hormone*
  99. Differential Effects of Thyrotropin-Releasing Hormone on in vitro Release of in vivo or in vitro Newly Synthesized and Mature Prolactin by Lactating Rat Adenohypophyses
  100. Biological and Immunological Characterization of Cleaved and 16K Forms of Rat Prolactin*
  101. Analysis of the Proteolytic Cleavage of Prolactin by the Mammary Gland and Liver of the Rat: Characterization of the Cleaved and 16K Forms*
  102. Investigation into the role of dopamine and lysosomes in the impairment of prolactin transformation and release imposed by long periods of non-suckling in the rat
  103. Thiol Regulation of Depletion-Transformation and Release of Prolactin by the Pituitary of the Lactating Rat*
  104. Reversal by Thiols of Dopamine-, Stalk-Median Eminence-, and Zinc-Induced Inhibition of Prolactin Transformation in Adenohypophyses of Lactating Rats*
  105. Release of Catecholamines Follows Suckling or Electrical Stimulation of Mammary Nerve in Lactating Rats*
  106. In-vivo and in-vitro secretion of prolactin by lactating rat adenohypophyses as a function of intracellular age
  107. REGULATORY AND CONTROL MECHANISMS OF PROLACTIN SECRETION WITHIN THE PITUITARY OF THE LACTATING RAT
  108. A Solubility Shift Occurs during Depletion-Transformation of Prolactin within the Lactating Rat Pituitary*
  109. Latency and duration of the effects of bromocriptine and prolactin on milk secretion in lactating rabbits
  110. Effect of Acute Increases in Suckling Frequency upon Food Intake and Milk Secretion in the Rabbit